Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Immucell (ICCC) Receivables - Net (2016 - 2025)

Immucell (ICCC) has disclosed Receivables - Net for 16 consecutive years, with $2.6 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Receivables - Net rose 10.7% year-over-year to $2.6 million, compared with a TTM value of $2.6 million through Sep 2025, up 10.7%, and an annual FY2024 reading of $3.8 million, up 72.56% over the prior year.
  • Receivables - Net was $2.6 million for Q3 2025 at Immucell, up from $2.4 million in the prior quarter.
  • Across five years, Receivables - Net topped out at $3.8 million in Q4 2024 and bottomed at $1.4 million in Q2 2022.
  • Average Receivables - Net over 5 years is $2.3 million, with a median of $2.3 million recorded in 2024.
  • The sharpest move saw Receivables - Net surged 108.57% in 2021, then tumbled 34.73% in 2022.
  • Year by year, Receivables - Net stood at $2.7 million in 2021, then crashed by 34.73% to $1.8 million in 2022, then rose by 24.27% to $2.2 million in 2023, then skyrocketed by 72.56% to $3.8 million in 2024, then tumbled by 32.25% to $2.6 million in 2025.
  • Business Quant data shows Receivables - Net for ICCC at $2.6 million in Q3 2025, $2.4 million in Q2 2025, and $3.3 million in Q1 2025.